Medable vaccine diary
Speed. Ease. Expertise.

Because viruses don't wait for paperwork

Our pre-built and scalable vaccine offering enable faster trials, better site and patient experiences, and expedited data delivery.

Scale to fit your trial needs


Deploy quickly with pre-built Core

Deploy in as little as five weeks—while confidently meeting industry standards—with our pre-built set of tools intentionally configured for vaccine trial.

Our Core tools include:

  • eScreening
  • eConsent
  • TeleVisit and Scheduling capabilities
  • eCOA
  • Customized notifications and reporting

Scale efficiently with Flex

It’s Core—with more. In addition to Core tools, Flex offers you a custom set of digital products tailored by our subject matter experts to meet your protocol’s needs.

With Flex, you also benefit from:

  • Sensors and wearables
  • More complex COAs
  • Advanced system integrations
  • Additional language support
  • Access to partner capabilities
“This solution eliminates much of the technical build burden and can reduce trial launch timelines from more than 12 weeks on average”
Musaddiq Khan

VP Therapeutic Area Solutions - Customer Value Team

Vaccine specific experience, partnered with vaccine experts




Languages Enabled


Platform Participants

Frequently asked questions

How quickly can my Vaccine clinical trial begin?

With our “Core” vaccine offering you can deploy your trial  in as little as 5 weeks from PDS to go-live.

Does Medable’s Vaccine Offering optimize participant safety?

Yes! Our platform provides real-time access to key safety data throughout your trial.

Is the DCT approach good for vaccine trials?

Yes. The need for rapid enrollment, changes in affected area, and need to remotely collect data are perfect for our pre-built solutions.

Will this Vaccine Offering work for my trial?

If it is a vaccine study, our offering is able to service your unique vaccine trial’s needs. Our SMEs can review protocol requirements and confirm it’s a good fit for our digital trial solutions.

How is this different from what other companies offer?

The Vaccine offering is a pre-built, standardized solution that can be rapidly deployed and scaled across your portfolio.

The latest in vaccines

Participant submitting eCOAs
White Papers, Case Studies, Reports

Medable enables >90% eCOA adherence in vaccine trial

6 min

A leading biotech company came to Medable looking to conduct a vaccine trial. They were concerned that their trial’s participant population of persons aged 50+ years may be hesitant to use the sponsors’ chosen eCOAtrial technology, would not be engaged in the study, and therefore may not provide consistent trial data.

Learn how we drove success for them, including >90% eCOA adherence.

Blog posts

Bridging the gap: Ensuring sites are successful with Medable

For years, clinical research sites have been vocal about the technological challenges they face conducting trials. Obstacles such as multiple disparate systems per trial, an abundance of passwords, lack of interoperability, and other issues all showcase how technology can be as significant a hindrance as it is a boon. As a recent Forbes article suggests, if clinical research technology doesn’t empower sites, it risks slowing down the entire trial.

Blog posts

How we standardized deploying vaccine studies in five weeks

By Musaddiq Khan, VP, DCT Solutions

At Medable, we’re always looking to understand the changing environment of clinical research, and how we can help customers overcome the various challenges, risks, and scenarios that these changes bring.

For the past year, I, various clinicians, and research experts at Medable have been working closely to improve how we conduct research for various therapeutic areas. Much like the results shown in Tufts CSDD’s latest whitepaper, we believe that a well-thought, decentralized approach can help bring new therapies in historically challenging therapeutic areas to markets faster.

The result of this work is a brand-new decentralized approach we’re bringing to the market.

See how Medable can make your trials more efficient.